Uric acid modulates vascular endothelial function through the down regulation of nitric oxide production

Area of Science:

• Cardiovascular Science
• Endothelial Biology
• Metabolic Health

Background:

• Endothelial dysfunction, marked by reduced nitric oxide (NO) bioavailability, initiates coronary artery disease (CAD).
• Hyperuricemia, elevated plasma uric acid, is a risk factor for CAD, but its direct causal link remains unproven.
• Understanding uric acid's impact on NO is crucial for clarifying its role in cardiovascular risk.

Purpose of the Study:

• To investigate the direct effect of uric acid on endothelial NO bioavailability.
• To elucidate the mechanisms by which uric acid influences NO production and endothelial function.

Main Methods:

• Electrochemical measurement of NO production in acetylcholine-stimulated human umbilical endothelial cells (HUVECs).
• Organ bath experiments assessing endothelium-dependent vasorelaxation in mouse aortic segments.
• Assays for reactive oxygen species (ROS) production, arginase activity, and endothelial NO synthase (eNOS) phosphorylation in HUVECs.

Main Results:

• Uric acid significantly decreased NO release from HUVECs and impaired vasorelaxation in mouse aortic rings.
• Uric acid increased arginase activity and reduced eNOS phosphorylation, indicating impaired NO synthesis.
• Uric acid elevated intracellular superoxide formation, suggesting oxidative stress contributes to NO reduction.

Conclusions:

• Uric acid diminishes NO bioavailability through multiple mechanisms, including increased arginase activity and oxidative stress.
• These findings provide mechanistic support for a causal association between hyperuricemia and cardiovascular risk.
• Targeting uric acid may offer a novel strategy for preventing or managing cardiovascular disease.